Principal Financial Group’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,497
| Closed | -$50.4K | – | 2396 |
|
|
2024
Q1 | $50.4K | Sell |
12,497
-2,719
| -18% | -$11K | ﹤0.01% | 2343 |
|
|
2023
Q4 | $40.3K | Sell |
15,216
-701,602
| -98% | -$1.86M | ﹤0.01% | 2346 |
|
|
2023
Q3 | $1.69M | Sell |
716,818
-11,403
| -2% | -$26.9K | ﹤0.01% | 1785 |
|
|
2023
Q2 | $4.59M | Buy |
728,221
+8,284
| +1% | +$52.2K | ﹤0.01% | 1556 |
|
|
2023
Q1 | $4.15M | Sell |
719,937
-62,772
| -8% | -$362K | ﹤0.01% | 1599 |
|
|
2022
Q4 | $8.03M | Sell |
782,709
-37,277
| -5% | -$382K | 0.01% | 1356 |
|
|
2022
Q3 | $13.7M | Buy |
819,986
+66,293
| +9% | +$1.11M | 0.01% | 1007 |
|
|
2022
Q2 | $10.6M | Buy |
753,693
+209,781
| +39% | +$2.94M | 0.01% | 1227 |
|
|
2022
Q1 | $8.78M | Buy |
543,912
+21,458
| +4% | +$347K | 0.01% | 1445 |
|
|
2021
Q4 | $11.2M | Buy |
522,454
+301,944
| +137% | +$6.46M | 0.01% | 1331 |
|
|
2021
Q3 | $3.24M | Buy |
220,510
+9,008
| +4% | +$132K | ﹤0.01% | 1791 |
|
|
2021
Q2 | $4.21M | Buy |
211,502
+104,094
| +97% | +$2.07M | ﹤0.01% | 1760 |
|
|
2021
Q1 | $3.21M | Buy |
+107,408
| New | +$3.21M | ﹤0.01% | 1771 |
|